B. Aungst

发表

Buccal and oral bioavailability of nalbuphine in rats.

M. Hussain, E. Shefter, B. Aungst, 1986, Journal of pharmaceutical sciences.

An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases.

M. Hussain, C. Koval, A. Shenvi, 1990, Life sciences.

Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.

M. Hussain, C. Koval, A. Shenvi, 1990, Journal of pharmaceutical sciences.

Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailability.

M. Hussain, S. Mousa, R. Kapil, 1997, Journal of pharmaceutical sciences.

Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery.

M. Hussain, B. Aungst, S. Rowe, 1990, Journal of pharmaceutical sciences.

Intranasal absorption of oxymorphone.

M. Hussain, B. Aungst, B. Aungst, 1997, Journal of pharmaceutical sciences.

Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles.

M. Hussain, B. Aungst, N. J. Rogers, 1990, Journal of pharmaceutical sciences.

Sustained Propranolol Delivery and Increased Oral Bioavailability in Dogs Given a Propranolol Laurate Salt

M. Hussain, B. Aungst, 1992, Pharmaceutical Research.

An in vitro evaluation of metabolism and poor membrane permeation impeding intestinal absorption of leucine enkephalin, and methods to increase absorption.

M. Hussain, J. A. Blake, B. Aungst, 1991, The Journal of pharmacology and experimental therapeutics.

Nasal mucosal metabolism and absorption of pentapeptide enkephalin analogs having varying N-terminal amino acids.

M. Hussain, R. Seetharam, C. Kettner, 1995, Journal of pharmaceutical sciences.